Company No:
Contents
| Note | 30.09.2025 | |
| £ | ||
| Fixed assets | ||
| Investments | 3 |
|
| 1,407,000 | ||
| Creditors: amounts falling due within one year | 4 | (
|
| Net current liabilities | (318,596) | |
| Total assets less current liabilities | 1,088,404 | |
| Net assets |
|
|
| Capital and reserves | ||
| Called-up share capital | 5 |
|
| Share premium account |
|
|
| Profit and loss account |
|
|
| Total shareholders' funds |
|
Directors' responsibilities:
The financial statements of Morris Hargreaves McIntyre Group Limited (registered number:
|
E M James
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.
Morris Hargreaves McIntyre Group Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Colony, 1 Silk Street, Manchester, M4 6LZ, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
These accounts cover the period from incorporation 20 September 2024 to 30 September 2025.
Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.
Investments in subsidiaries are measured at cost less accumulated impairment.
| Period from 20.09.2024 to 30.09.2025 |
|
| Number | |
| Monthly average number of persons employed by the Company during the period, including directors |
|
Investments in subsidiaries
| 30.09.2025 | |
| £ | |
| Cost | |
| At 20 September 2024 | 0 |
| Additions |
|
| At 30 September 2025 |
|
| Carrying value at 30 September 2025 |
|
| 30.09.2025 | |
| £ | |
| Amounts owed to Group undertakings |
|
| Other creditors |
|
|
|
| 30.09.2025 | |
| £ | |
| Allotted, called-up and fully-paid | |
|
|
|
|
|
|
|
|
|
|
|
|
| 1,000 | |
|
|
|
| 1,077 |
On 1 October 2024 the company issues 77 preference shares of £1 each at a premium of £769,923.